ASPC 2019 Congress on CVD Prevention

 

ASPC 2019 Congress on CVD Prevention
Avatar

Newer Insights Into Why the SGLT2s Reduce Heart Failure in Patients With Diabetes

By ASPC 2019 Congress on CVD Prevention FEATURING Robert Chilton
By ASPC 2019 Congress on CVD Prevention FEATURING Robert Chilton
1,411 views
August 9, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

02:17
Novartis Cardiology

Understanding Acquisition and Billing for a Non-Statin Lipid-Lowerin…

Feat. B. Buell

Featured Video

04:47
Novartis Cardiology

Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowe…

Session 2: Diabetes Mellitus
18:43

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

12.2K views
14:35

Newer Insights Into Why the SGLT2s Reduce Heart Failure in Patients …

ASPC 2019 Congress on CVD Prevention

R. Chilton

1.4K views
36:40

Hemoglobin A1c Redux: Yes, It Matters!

ASPC 2019 Congress on CVD Prevention

Y. Handelsman

403 views